Matthew Shawn Morris Sells 10,309 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) Director Matthew Shawn Morris sold 10,309 shares of the stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $240,508.97. Following the completion of the transaction, the director now owns 59,792 shares of the company’s stock, valued at $1,394,947.36. The trade was a 14.71 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Privia Health Group Price Performance

NASDAQ PRVA opened at $23.32 on Friday. The stock has a market capitalization of $2.83 billion, a P/E ratio of 233.22, a P/E/G ratio of 3.47 and a beta of 0.88. The business has a 50 day simple moving average of $23.50 and a 200 day simple moving average of $22.07. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $26.04.

Institutional Trading of Privia Health Group

Several large investors have recently modified their holdings of the stock. First Horizon Advisors Inc. boosted its stake in Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after acquiring an additional 632 shares in the last quarter. CWM LLC grew its stake in shares of Privia Health Group by 50.3% in the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock valued at $40,000 after buying an additional 604 shares during the period. EverSource Wealth Advisors LLC increased its position in Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after buying an additional 2,350 shares in the last quarter. Financial Management Professionals Inc. acquired a new position in Privia Health Group during the 4th quarter worth approximately $51,000. Finally, Bessemer Group Inc. boosted its holdings in Privia Health Group by 2,393.4% in the first quarter. Bessemer Group Inc. now owns 2,269 shares of the company’s stock worth $51,000 after acquiring an additional 2,178 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Analysts Set New Price Targets

PRVA has been the subject of several research reports. Truist Financial increased their target price on Privia Health Group from $27.00 to $28.00 and gave the company a “buy” rating in a research report on Thursday, April 10th. Needham & Company LLC reiterated a “buy” rating and set a $30.00 target price on shares of Privia Health Group in a research report on Thursday, April 10th. JMP Securities restated a “market outperform” rating and issued a $29.00 price target on shares of Privia Health Group in a research report on Monday, April 28th. Canaccord Genuity Group raised their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, February 28th. Finally, Robert W. Baird boosted their price objective on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 15th. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Privia Health Group has an average rating of “Buy” and a consensus target price of $27.38.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.